Currently predicting for Mon, 1 Apr 2024

Trading levels for PLX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.30 3.17 %
R2 1.28 1.96 %
R1 1.28 1.21 %
Current price: 1.26
Support S1 1.24 -1.21 %
S2 1.24 -1.96 %
S3 1.22 -3.17 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.48 17.46 %
R2 1.47 16.67 %
R1 1.37 8.73 %
Current price 1.26
Support S1 1.25 -0.794%
S2 1.22 -3.17%
S3 0 .

PLX Predictions History

2 years ago
Rybkarybka predicted that PLX for 2021-11-01 is going $1.16 (5.45%)

2 years ago
JS predicted that PLX for 2021-10-28 is going $1.10 (-1.79%)

2 years ago
AlexVel predicted that PLX for 2021-10-28 is going $1.08 (-3.57%)

2 years ago
Rybkarybka predicted that PLX for 2021-10-28 is going $1.14 (2.70%)

2 years ago
Rybkarybka predicted that PLX for 2021-10-19 is going $1.33 (7.26%)

2 years ago
Rybkarybka predicted that PLX for 2021-10-15 is going $1.35 (9.76%)

2 years ago
JS predicted that PLX for 2021-10-12 is going $1.23 (0.82%)

2 years ago
Rybkarybka predicted that PLX for 2021-10-12 is going $1.27 (4.10%)

2 years ago
Rybkarybka predicted that PLX for 2021-10-11 is going $1.38 (3.76%)

2 years ago
RamboRex3000 predicted that PLX for 2021-08-27 is going $1.51 (-5.63%)

Click to get the best stock tips daily for free!

About Protalix BioTherapeutics Inc

Protalix BioTherapeutics Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso for the treatment of Gaucher disease. Its product pipeline comprises PRX-102, a therapeutic protein candi... PLX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT